This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2014 Sep 11;371(11):1039-49.

doi: 10.1056/NEJMra1404198.

Pancreatic adenocarcinoma

David P Ryan¹, Theodore S Hong, Nabeel Bardeesy

Affiliations

Affiliation

¹ From the Division of Hematology-Oncology, Department of Medicine (D.P.R., N.B.), and the Department of Radiation Oncology (T.S.H.), Massachusetts General Hospital, Boston.

PMID: 25207767
DOI: 10.1056/NEJMra1404198

Review

Pancreatic adenocarcinoma

David P Ryan et al. N Engl J Med. 2014.

. 2014 Sep 11;371(11):1039-49.

doi: 10.1056/NEJMra1404198.

Authors

David P Ryan¹, Theodore S Hong, Nabeel Bardeesy

Affiliation

¹ From the Division of Hematology-Oncology, Department of Medicine (D.P.R., N.B.), and the Department of Radiation Oncology (T.S.H.), Massachusetts General Hospital, Boston.

PMID: 25207767
DOI: 10.1056/NEJMra1404198

No abstract available

PubMed Disclaimer

Comment in

Pancreatic adenocarcinoma.
Ryan DP, Hong TS, Bardeesy N. Ryan DP, et al. N Engl J Med. 2014 Nov 27;371(22):2140-1. doi: 10.1056/NEJMc1412266. N Engl J Med. 2014. PMID: 25427123 No abstract available.
Pancreatic adenocarcinoma.
Bükki J. Bükki J. N Engl J Med. 2014 Nov 27;371(22):2139-40. doi: 10.1056/NEJMc1412266. N Engl J Med. 2014. PMID: 25427124 No abstract available.
Pancreatic adenocarcinoma.
Moyer MT, Gaffney RR. Moyer MT, et al. N Engl J Med. 2014 Nov 27;371(22):2140. doi: 10.1056/NEJMc1412266. N Engl J Med. 2014. PMID: 25427125 No abstract available.

Similar articles

Optimizing methods for the diagnosis of pancreatic cancer.
Brugge WR. Brugge WR. J Clin Gastroenterol. 2007 Nov-Dec;41(10):869-70. doi: 10.1097/MCG.0b013e318146849f. J Clin Gastroenterol. 2007. PMID: 18090153 No abstract available.
Use of predictive markers in oncology: are phase 3 trials always required?
Markman M. Markman M. Oncology. 2011;81(1):1-2. doi: 10.1159/000330729. Epub 2011 Sep 2. Oncology. 2011. PMID: 21894048 No abstract available.
Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Strzelczyk J, Janiak A, Kulig A, Malecka-Panas E. Talar-Wojnarowska R, et al. J Physiol Pharmacol. 2004 Jul;55 Suppl 2:129-38. J Physiol Pharmacol. 2004. PMID: 15608367
Targets, trials, and travails in pancreas cancer.
Izeradjene K, Hingorani SR. Izeradjene K, et al. J Natl Compr Canc Netw. 2007 Nov;5(10):1042-53. doi: 10.6004/jnccn.2007.0087. J Natl Compr Canc Netw. 2007. PMID: 18053428 Review.
[Progress of targeted therapy related to K-ras mutation].
Li ZW, Liu YQ. Li ZW, et al. Zhonghua Bing Li Xue Za Zhi. 2012 Jan;41(1):59-61. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22455857 Review. Chinese. No abstract available.

See all similar articles

Cited by

PRIM2 promotes proliferation and metastasis of pancreatic ductal adenocarcinoma through interactions with FAM111B.
Yin J, Qin F, Chen H, Wang X, Xia R, Ni B, Wang H. Yin J, et al. Med Oncol. 2024 Nov 18;42(1):6. doi: 10.1007/s12032-024-02554-8. Med Oncol. 2024. PMID: 39556158
Lfng-expressing centroacinar cell is a unique cell-of-origin for p53 deficient pancreatic cancer.
Chung WC, Zhang S, Atfi A, Xu K. Chung WC, et al. Oncogene. 2024 Nov 15. doi: 10.1038/s41388-024-03226-7. Online ahead of print. Oncogene. 2024. PMID: 39548190
A Tumor Homing Peptide-Linked Arsenic Compound Inhibits Pancreatic Cancer Growth and Enhances the Inhibitory Effect of Gemcitabine.
He H, Dumesny C, Carrall JA, Dillon CT, de Roo KI, Eutick M, Dong L, Baldwin GS, Nikfarjam M. He H, et al. Int J Mol Sci. 2024 Oct 22;25(21):11366. doi: 10.3390/ijms252111366. Int J Mol Sci. 2024. PMID: 39518921 Free PMC article.
Single-cell transcriptome analysis identifies a novel tumor-associated macrophage subtype predicting better prognosis in pancreatic ductal adenocarcinoma.
Wang X, Li D, Zhu B, Hua Z. Wang X, et al. Front Cell Dev Biol. 2024 Oct 23;12:1466767. doi: 10.3389/fcell.2024.1466767. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39507421 Free PMC article.
DNA methylation biomarker panels for differentiating various liver adenocarcinomas, including hepatocellular carcinoma, cholangiocarcinoma, colorectal liver metastases and pancreatic adenocarcinoma liver metastases.
Draškovič T, Ranković B, Zidar N, Hauptman N. Draškovič T, et al. Clin Epigenetics. 2024 Nov 4;16(1):153. doi: 10.1186/s13148-024-01766-z. Clin Epigenetics. 2024. PMID: 39497215 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal